A nationwide snapshot study on outcomes one year after surgery for chronic pilonidal sinus disease.

IF 2.9 3区医学 Q2 GASTROENTEROLOGY & HEPATOLOGY

Colorectal Disease Pub Date : 2024-12-02 DOI:10.1111/codi.17217

Eleonora A Huurman, Christel A L de Raaff, Rosaline van den Berg, Sara J Baart, Bas P L Wijnhoven, Ruben Schouten, Edgar J B Furnée, Robert M Smeenk, Boudewijn R Toorenvliet

{"title":"A nationwide snapshot study on outcomes one year after surgery for chronic pilonidal sinus disease.","authors":"Eleonora A Huurman, Christel A L de Raaff, Rosaline van den Berg, Sara J Baart, Bas P L Wijnhoven, Ruben Schouten, Edgar J B Furnée, Robert M Smeenk, Boudewijn R Toorenvliet","doi":"10.1111/codi.17217","DOIUrl":null,"url":null,"abstract":"Aim: Managing pilonidal sinus disease (PSD) remains challenging due to high recurrence rates and morbidity associated with treatment. The aim of this study was to evaluate the outcomes one year after surgical treatment for chronic PSD in the Netherlands.Method: Patients with PSD who underwent surgical treatment between March 1, 2020, and March 1, 2021, at 36 participating hospitals were included in a prospective observational cohort study. For the present study, only patients with chronic PSD were included for analysis. One-year after surgical treatment for PSD, all patients received questionnaires on wound healing, quality of life (QoL), and patient reported experience measures (PREMs). Primary outcome was recurrence rate. Secondary outcomes included QoL and PREMs.Results: Of 681 included patients, 405 patients presented with chronic PSD and underwent surgical treatment. One-year questionnaires were completed by 289 out of 405 patients (71.4%). Patients underwent either excision with secondary wound healing (ESW, n = 73), excision with midline closure (EMC, n = 21), off-midline closure (OMC, n = 17), or a minimally invasive technique (MIT, n = 178). Patient-reported recurrence rates after ESW, EMC, OMC and MIT were 21.5%, 25%, 6.7% and 30.6%, respectively. Pain/discomfort and anxiety/depression were the most frequently reported problems affecting QoL. Patients that underwent OMC were satisfied the most with the care provided.Conclusion: This study demonstrates variation in recurrence rates among surgical procedures for PSD. The highest rates were observed in the MIT and EMC group, while the OMC group exhibited the lowest rate. QoL outcomes differed among the surgical techniques. Patient satisfaction appears highest in the OMC group.","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colorectal Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/codi.17217","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Aim: Managing pilonidal sinus disease (PSD) remains challenging due to high recurrence rates and morbidity associated with treatment. The aim of this study was to evaluate the outcomes one year after surgical treatment for chronic PSD in the Netherlands.

Method: Patients with PSD who underwent surgical treatment between March 1, 2020, and March 1, 2021, at 36 participating hospitals were included in a prospective observational cohort study. For the present study, only patients with chronic PSD were included for analysis. One-year after surgical treatment for PSD, all patients received questionnaires on wound healing, quality of life (QoL), and patient reported experience measures (PREMs). Primary outcome was recurrence rate. Secondary outcomes included QoL and PREMs.

Results: Of 681 included patients, 405 patients presented with chronic PSD and underwent surgical treatment. One-year questionnaires were completed by 289 out of 405 patients (71.4%). Patients underwent either excision with secondary wound healing (ESW, n = 73), excision with midline closure (EMC, n = 21), off-midline closure (OMC, n = 17), or a minimally invasive technique (MIT, n = 178). Patient-reported recurrence rates after ESW, EMC, OMC and MIT were 21.5%, 25%, 6.7% and 30.6%, respectively. Pain/discomfort and anxiety/depression were the most frequently reported problems affecting QoL. Patients that underwent OMC were satisfied the most with the care provided.

Conclusion: This study demonstrates variation in recurrence rates among surgical procedures for PSD. The highest rates were observed in the MIT and EMC group, while the OMC group exhibited the lowest rate. QoL outcomes differed among the surgical techniques. Patient satisfaction appears highest in the OMC group.

查看原文本刊更多论文

一项全国范围内对慢性毛窦疾病手术后一年结果的快照研究。

目的：由于高复发率和与治疗相关的发病率，治疗毛鞘窦疾病（PSD）仍然具有挑战性。本研究的目的是评估荷兰慢性PSD手术治疗一年后的结果。方法：将2020年3月1日至2021年3月1日期间在36家参与医院接受手术治疗的PSD患者纳入前瞻性观察队列研究。在本研究中，仅纳入慢性PSD患者进行分析。手术治疗PSD一年后，所有患者接受伤口愈合、生活质量（QoL）和患者报告体验量表（PREMs）的问卷调查。主要观察指标为复发率。次要结局包括QoL和PREMs。结果：在681例纳入的患者中，405例患者表现为慢性PSD并接受了手术治疗。405例患者中有289例（71.4%）完成了为期一年的问卷调查。患者接受了继发性伤口愈合切除（ESW, n = 73）、中线闭合切除（EMC, n = 21）、非中线闭合切除（OMC, n = 17）或微创技术（MIT, n = 178）。ESW、EMC、OMC和MIT术后复发率分别为21.5%、25%、6.7%和30.6%。疼痛/不适和焦虑/抑郁是影响生活质量的最常见问题。接受OMC的患者对所提供的护理最满意。结论：本研究表明不同手术方式治疗PSD的复发率存在差异。以MIT组和EMC组发生率最高，而OMC组发生率最低。生活质量结果因手术技术而异。患者满意度在OMC组中最高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Colorectal Disease 医学-胃肠肝病学

CiteScore

6.10

自引率

11.80%

发文量

406

审稿时长

1.5 months

期刊介绍： Diseases of the colon and rectum are common and offer a number of exciting challenges. Clinical, diagnostic and basic science research is expanding rapidly. There is increasing demand from purchasers of health care and patients for clinicians to keep abreast of the latest research and developments, and to translate these into routine practice. Technological advances in diagnosis, surgical technique, new pharmaceuticals, molecular genetics and other basic sciences have transformed many aspects of how these diseases are managed. Such progress will accelerate. Colorectal Disease offers a real benefit to subscribers and authors. It is first and foremost a vehicle for publishing original research relating to the demanding, rapidly expanding field of colorectal diseases. Essential for surgeons, pathologists, oncologists, gastroenterologists and health professionals caring for patients with a disease of the lower GI tract, Colorectal Disease furthers education and inter-professional development by including regular review articles and discussions of current controversies. Note that the journal does not usually accept paediatric surgical papers.